# Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD

> **NCT04192110** · PHASE4 · WITHDRAWN · sponsor: **VA Office of Research and Development**

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** Diuretic initiation or augmentation

## Key facts

- **NCT ID:** NCT04192110
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-08-11
- **Primary completion:** 2020-08-11
- **Final completion:** 2020-08-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The project has ended prior to beginning.
- **Last updated:** 2021-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04192110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04192110, "Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04192110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*